The latest gynaecological cancer news
Perception-based nanosensor platform could advance detection of ovarian cancer
Ovarian cancer kills 14,000 women in the United States every year. It’s the fifth leading…
Browsing: Gynaecologic Cancers
Ovarian cancer is not a silent killer
Barbara Goff, University of Washington Ovarian cancer is the most deadly of gynecologic tumours. Fewer…
Protected: The evolving ovarian cancer treatment algorithm: What’s new for your patients in 2022?
This content is password-protected. To view it, please enter the password below. Password:
Hidden vulnerability in ovarian and uterine cancers identified
Although the outlook for people with some types of cancers has improved in the past…
Updated guidelines prepare health professionals for cervical screening ‘game-changer’
Updated national cervical cancer clinical guidelines now provide the latest advice on the expanded eligibility…
Single-dose HPV vaccine recommendation is a “game changer” for cervical cancer elimination
Just one dose of the human papillomavirus (HPV) vaccine is enough to provide sufficient protection…
Key characteristics of immune cells in ovarian cancer
Treatments for ovarian cancer have changed little over the past few decades, with surgery and…
How ovarian cancer defies immunotherapy
Researchers at University of California San Diego School of Medicine and Moores Cancer Center at…
Trial indicates using atezolizumab with chemoradiation is safe in women with cervical cancer
A Phase I/Ib trial conducted by the National Cancer Institute (NCI) National Clinical Trials Network…
SGO 2022: Biomarker Analysis of the NRG Oncology NRG-GY004 Trial
Results of a biomarker analysis of the NRG Oncology NRG-GY004 trial were presented at a…